Shaanxi Meibang Pharmaceutical Group Co., Ltd.SSE: 605033

Report for Q3 2025

· Issued by Shaanxi Meibang Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE ·

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shaanxi Meibang Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Shaanxi Meibang Pharmaceutical

Later from Shaanxi Meibang Pharmaceutical

All Shaanxi Meibang Pharmaceutical news releases